Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of February 28, 2021
How do antibodies evolve to kill HIV-infected cells?
From the Overbaugh and Matsen labs, Human Biology and Public Health Sciences Division
Neutralizing the foe: tracking the immune response to SARS-CoV-2 infection
From the Bloom Lab, Basic Sciences Division
Antibody blocks Epstein-Barr virus in preclinical trial
Hutch-discovered protein blocks virus linked to cancers, mono, autoimmune diseases
Validating antibody tests to determine SARS-CoV-2 seroprevalence
From the University of Washington and the Jerome lab, Vaccine and Infectious Disease Division
Studying how maternal immune factors shape infant health
Immunologist Dr. Megan Koch named 2020 Pew Scholar in the Biomedical Sciences
Studying the complex interactions between antibodies and viral targets
Bloom Lab postdoc Dr. Tal Einav named Damon Runyon Quantitative Biology Fellow
New research projects aim to advance COVID-19 testing, treatment
Projects by Drs. Keith Jerome, Andrew McGuire funded by $350,000 gift from M.J. Murdock Charitable Trust
Defining the role of maternal neutralizing antibodies in mother-to-child HIV transmission
From the Overbaugh laboratory, Human Biology Division
Hutch team hunts for coronavirus antibodies
Screening blood from survivors to find immune proteins for treatments and guide vaccine research
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
HIV vaccine trial uncovers plausible mechanisms of protection
From the HVTN, Vaccine and Infectious Disease Division
Engineering B cells to bypass vaccines
From the Taylor Lab, Vaccine and Infectious Disease Division
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
Cancer cells BiTE the dust through SMITE-bispecific mediated T cell activation
- from the Walter's and Mehlin's labs, Clinical Research Division
New antibody and unique binding site offer possible paths to malaria prevention
Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
Deciphering how influenza escapes neutralizing antibodies
From the Bloom Laboratory, Basic Sciences Division
Good News: $475K gift fuels expansion of antibody tech; Hansen honored for BMT work; Senate passes 21st Century Cures Act
Celebrating faculty and staff achievements
Good News: Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response
Celebrating faculty and staff achievements